Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction (Q37957560)

25 August 2017

Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction (English)

1 reference

25 August 2017

0 references

3

Steven B Heymsfield

1 reference

25 August 2017

Priscila C Sala

1

1 reference

PubMed ID

22094369

25 August 2017

Raquel S Torrinhas

series ordinal

2

1 reference

PubMed ID

22094369

25 August 2017

Dan L Waitzberg

series ordinal

4

1 reference

25 August 2017

1 January 2012

1 reference

25 August 2017

1 reference

25 August 2017

22

1 reference

25 August 2017

167-176

1 reference

25 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-011-0563-2

25 August 2017

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Multifaceted therapeutic approaches for a multigenic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Trends in diabetes mellitus in Brazil: the role of the nutritional transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Standards of medical care in diabetes--2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Bariatric surgery: risks and rewards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Bariatric surgery for type 2 diabetes: weighing the impact for obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Laparoscopic adjustable gastric banding for patients with body mass index of <or=35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The role of gut hormones in glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The new functions of the gut in the control of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Fructose-responsive genes in the small intestine of neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Effects of low protein intake on extra-hepatic gluconeogenic enzyme expression and peripheral glucose phosphorylation in rainbow trout (Oncorhynchus mykiss).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Broad expression of fructose‐1,6‐bisphosphatase and phosphoenolpyruvate carboxykinase provide evidence for gluconeogenesis in human tissues other than liver and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Mechanism for improved insulin sensitivity after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Glucose Metabolism and Regulation: Beyond Insulin and Glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Extrapancreatic Glucagons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Identical mRNA for preproglucagon in pancreas and gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

All products of proglucagon are elevated in plasma from uremic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Bariatric surgery and the gut hormone response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Biliopancreatic diversion with a duodenal switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Ghrelin and energy balance: focus on current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Proglucagon-derived peptides: mechanisms of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Peptide YY levels are elevated after gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Circulating glucagon after total pancreatectomy in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Antidiabetogenic Action of Cholecystokinin-8 in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0563-2

Gastric banding using adjustable silastic ring in 2010. Technique, indications, results, and management

21 January 2018

1 reference

12 December 2020

Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia

1 reference

12 December 2020

Insulinotropic action of human glicentin in dogs

1 reference

12 December 2020

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

12 December 2020

Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes

1 reference

12 December 2020

How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number

1 reference

12 December 2020

The decline and fall of the jejunoileal bypass

1 reference

12 December 2020

Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing

1 reference

12 December 2020

Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

Vertical gastroplasty: evolution of vertical banded gastroplasty

1 reference

12 December 2020

Nonhepatic glucose production in humans

1 reference

12 December 2020

Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?

1 reference

12 December 2020

Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation

1 reference

12 December 2020

Biliopancreatic diversion for obesity at eighteen years

1 reference

12 December 2020

Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats

1 reference

12 December 2020

Complete sequences of glucagon-like peptide-1 from human and pig small intestine

1 reference

12 December 2020

Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss

1 reference

12 December 2020

Pancreatic and intestinal processing of proglucagon in man.

1 reference

12 December 2020

Surgical treatment of morbid obesity

1 reference

12 December 2020

On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus

1 reference

12 December 2020

The New Biology of Gastrointestinal Hormones

1 reference

12 December 2020

The primary structure of porcine glicentin (proglucagon)

1 reference

12 December 2020

Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.

1 reference

12 December 2020

An experimental evaluation of the nutritional importance of proximal and distal small intestine

1 reference

12 December 2020

10.1007/S11695-011-0563-2

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22094369